UNSPSC 51172169: Drofenine hydrochloride

This classification denotes an antispasmotic agent and antimuscarinic agent with the molecular formula C20H31NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MVB31OPW05, chemically known as cyclohexaneacetic acid, alpha-phenyl-, 2-(diethylamino)ethyl ester, hydrochloride but more generally known as drofenine hydrochloride, which bears US NIH Compound Identifier 92806. European Medicines Agency schedules Drofenine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01838MIG.

Most nations, for tariff and trade purposes, schedule drofenine hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, DROFENINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CCN(CC)CCOC(=O)C(C1CCCCC1)C2CCCCC2.CL.

UNSPSC 51172169 Drofenine hydrochloride is a Commodity code that in current state and local procurement activity covers offender drug testing services, including specimen collection, lab analysis, and result reporting rather than the pharmaceutical product its name suggests. Collin County Community Supervision and Corrections Department is the primary recent issuing body under this code, procuring integrated testing programs that combine collection-site staffing, immunoassay screening with confirmatory testing (LC/MS/MS or GC/MS), and alternative methodologies including oral fluid and hair analysis. The scope includes operation of randomized testing notification systems and electronic result reporting, with vendors required to maintain SAMHSA, Texas DPS, or CAP lab certification. Evaluation weights vendor understanding and qualifications at 55 points, client references at 15 points, and cost at 30 points, with optional demonstrations and interviews adding up to 30 points; the award goes to the responsible contractor offering the best evaluated combination of price and qualifications.

Collin County in Texas represents the active recent geography under this code. The county issued RFP 2026-327 for offender specimen collection and drug testing services on September 25, 2026, with proposals due July 23, 2026, estimated contract value of $600,000, a two-year term commencing September 1, 2026, and three optional one-year renewals. The scope encompasses staffing two collection sites in Plano and McKinney with approximately 25,031 annual tests across five-panel and six-panel screens, with pricing submitted on a per-test basis covering three service models (screening only, confirmation after screening, and screening with automatic confirmation of positives). Pricing must include all freight, delivery, insurance, and staffing with no additional surcharges, and price reductions are contractually required if the vendor offers lower rates elsewhere.